Wockhardt Limited Tamoxifen Export Data — India (DGFT 2022–2026)

Name: Wockhardt Limited Tamoxifen Export Records India — #6 Exporter, 9 Shipments, $409.8K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Tamoxifen

India Pharmaceutical Trade Intelligence

$14.7M220 Suppliers104 CountriesHS 30049048

ExportsIndia → UNITED STATES42.5%India → GERMANY24.0%

ImportsUNITED STATES → India$2.0M GREECE → India$8.4K

#1 Supplier: EUGIA PHARMA #1 Buyer: AUROBINDO PHARMA

Wockhardt Limited — Tamoxifen Exporter #6 | $409.8K Trade Value | TransData Nexus | TransData Nexus

Wockhardt Limited — Tamoxifen Exporter Profile

Indian Pharmaceutical Exporter · #6 for Tamoxifen · $409.8K export value · DGFT Verified

Wockhardt Limited is the #6 Indian exporter of Tamoxifen with $409.8K in export value and 9 verified shipments. Wockhardt Limited holds a 2.8% market share in Tamoxifen exports across 1 countries. The company exports 10 pharmaceutical products worth $44.5M across 7 therapeutic categories.

Wockhardt Limited — Tamoxifen Export Profile: Buyers & Destinations

Wockhardt Limited Tamoxifen export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Tamoxifen?

Country	Value	Shipments	Share
UNITED STATES	$6.3M	160	53.9%
UNITED KINGDOM	$1.6M	61	14.1%
BELGIUM	$1.2M	79	10.0%
THAILAND	$1.0M	43

Who Are the Top Buyers of Tamoxifen from India?

Buyer	Country	Value	Orders
AUROBINDO PHARMA USA., INC,	UNITED STATES	$2.5M	85
ALIUD PHARMA GMBH	GERMANY	$1.3M	25
AUROBINDO PHARMA USA INC	UNITED STATES	$1.2M	25
AUROLOGISTICS LLC, (AUROBINDO PHARM	UNITED STATES	$1.1M	23
BELLS HEALTHCARE	UNITED KINGDOM	$416.4K	13
WOCKHARDT UK LIMITED	UNITED KINGDOM	$409.8K	9
TILLOMED LABORATORIES LIMITED	UNITED KINGDOM	$404.1K	14
AUROBINDO PHARMA USA., INC	UNITED STATES	$351.2K	8
AUROLOGISTICS LLC AUROBINDO PHARM	UNITED STATES	$300.0K	6
AUROBINDO PHARMA USA.INC.,.	UNITED STATES	$200.0K	4

India's Tamoxifen is purchased by 377 buyers worldwide. The top buyer is AUROBINDO PHARMA USA., INC, (UNITED STATES), followed by ALIUD PHARMA GMBH and AUROBINDO PHARMA USA INC.

How Does Wockhardt Limited Compare to Nearest Tamoxifen Exporters?

Exporters ranked immediately above and below #6 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
4	BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED	$830.4K	48	2	$17.3K
5	KHANDELWAL LABORATORIES PRIVATE LIMITED	$742.7K	32	7	$23.2K
6	WOCKHARDT LIMITED ★	$409.8K	9	1	$45.5K
2	PRATAP ORGANICS PRIVATE LIMITED	$350.0K	7	1	$50.0K
7	STERIL-GENE LIFE SCIENCES PRIVATE LIMITED	$254.0K	9	1	$28.2K

Wockhardt Limited ranks #6 among 220 Indian Tamoxifen exporters. Average shipment value of $45.5K compared to the market average of $50.0K. The closest competitors by value are BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED and KHANDELWAL LABORATORIES PRIVATE LIMITED.

Which Indian Ports Ship Tamoxifen Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	776	24.7%
DELHI AIR CARGO ACC (INDEL4)	638	20.3%
SAHAR AIR	541	17.2%
DELHI AIR	301	9.6%
Bombay Air	177	5.6%
Delhi Air	91	2.9%
HYDERABAD AIR	80	2.5%
Bombay Air Cargo	57	1.8%

Geopolitical & Trade Policy Impact on Wockhardt Limited's Tamoxifen Exports

Wockhardt's export operations are influenced by various geopolitical factors. The Israel-Iran conflict has disrupted Red Sea shipping routes, leading to increased shipping costs and extended transit times for Indian pharmaceutical exporters. These disruptions pose challenges for time-sensitive products, particularly those requiring stringent cold-chain logistics. (pharmaceuticalcommerce.com)

In the U.S., recent tariff policies have introduced additional complexities. In August 2025, the U.S. imposed broad tariffs on imports from over 60 countries, including India, with rates reaching up to 39%. These tariffs have impacted nearly 55% of India's exports to the U.S., placing Indian pharmaceutical companies at a competitive disadvantage. (apnews.com)

Conversely, the U.S.-China trade tensions have created opportunities for Indian pharmaceutical companies to fill supply gaps in the American market. However, the overall impact of U.S. tariff policies remains a significant concern for exporters like Wockhardt.

In the European Union, compliance with the Falsified Medicines Directive (FMD) has become increasingly stringent. Indian exporters must invest in advanced serialization and traceability systems to meet these requirements, ensuring the authenticity and safety of pharmaceutical products in the EU market.

Wockhardt Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the U.S. FDA and the European Medicines Agency (EMA) enforcing stringent quality standards. India, housing over 600 U.S. FDA-approved manufacturing sites, faces challenges in maintaining compliance. In 2023, the U.S. FDA conducted more than 200 inspections in India, with plans to increase this number in 2024. (fact.net.in)

For Wockhardt, adherence to Good Manufacturing Practices (GMP) and other regulatory standards is crucial to sustain its export operations. The company's strategic focus on high-impact areas necessitates continuous investment in quality control systems and infrastructure to meet evolving global standards.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Tamoxifen shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Wockhardt Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 104+ countries, 377+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Tamoxifen

Tamoxifen

Wockhardt Limited — Tamoxifen Exporter Profile

Wockhardt Limited — Tamoxifen Export Profile: Buyers & Destinations

Where Does India Export Tamoxifen?

Who Are the Top Buyers of Tamoxifen from India?

What Is India's Total Tamoxifen Export Value and How Much Does Wockhardt Limited Contribute?

What Is the Average Shipment Value for Wockhardt Limited's Tamoxifen Exports?

How Does Wockhardt Limited Compare to Other Indian Tamoxifen Exporters?

Regulatory Requirements: Exporting Tamoxifen to Key Markets

United States — FDA

United Kingdom — MHRA

How Does Wockhardt Limited Compare to Nearest Tamoxifen Exporters?

Which Indian Ports Ship Tamoxifen Exports?

Geopolitical & Trade Policy Impact on Wockhardt Limited's Tamoxifen Exports

Wockhardt Limited — Regulatory Compliance & Quality Standards

About Wockhardt Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Tamoxifen Export Data from Wockhardt Limited

Tamoxifen Stats

Company Overview

Top Products by Wockhardt Limited

Related Analysis

Need Detailed Export Data?

Data Source